[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371663-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371663-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","expression-of-the-il-18-related-gene-ptx3-correlates-with-clinicopathological-features-and-prognosis-in-glioma-patients","Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients","","Glioma is a highly aggressive brain tumor with limited prognostic options, and this study evaluates PTX3 as a IL-18 signaling-related molecular factor linked to outcomes. RNA-seq and clinical data for glioma patients were analyzed from TCGA to build a nine-gene IL-18 signaling-related prognostic signature using LASSO Cox regression. PTX3 functions were assessed via GO, KEGG, and GSEA, with immune infiltration estimated by ssGSEA and validation by immunohistochemistry in 56 specimens.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/expression-of-the-il-18-related-gene-ptx3-correlates-with-clinicopathological-features-and-prognosis-in-glioma-patients/371663/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/expression-of-the-il-18-related-gene-ptx3-correlates-with-clinicopathological-features-and-prognosis-in-glioma-patients/371663.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about PTX3 in glioma?","Question",{"text":63,"@type":64},"The study investigates PTX3 expression in glioma and how it correlates with patient prognosis and clinicopathological features, motivated by insufficient understanding of PTX3’s molecular mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the prognostic signature constructed?",{"text":68,"@type":64},"A multigene prognostic signature was built from IL-18 signaling-related genes using LASSO Cox regression, resulting in a nine-gene signature including PTX3.",{"name":70,"@type":61,"acceptedAnswer":71},"How were immune infiltration and PTX3 relationships evaluated?",{"text":72,"@type":64},"Single-sample GSEA (ssGSEA) assessed associations between PTX3 expression and immune cell infiltration, and results highlighted correlations particularly with macrophages, neutrophils, T cells, and natural killer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371663,1790604137,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Submitted 19 February 2025 Accepted 9 June 2025  \nPublished 10 July 2025  \nCorresponding authors  \nJing Zhang, [2522017@zju.edu.cn](2522017@zju.edu.cn)  \nJinfang Xu, [xujinfang@zju.edu.cn](xujinfang@zju.edu.cn)[ ](xujinfang@zju.edu.cn)Academic editor  \nTokuko Haraguchi  \nAdditional Information and Declarations can be found on page 21  \nDOI 10.7717/peerj.19675  \n Copyright 2025 Wang et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nExpression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients  \nDelin Wang1 ,* , Cuimei Liu2 ,* , Bohao Sun3 , Xiaodong Zhang1 , Yejun Zhou1 , Zhonglin Hu1 , Duanzheng Cao1 , Jing Zhang3 and Jinfang Xu4  \n1 Department of Neurosurgery, Jiande First People's Hospital, Hangzhou, Zhejiang, China  \n2 Department of Neurology, Jiande First People's Hospital, Hangzhou, Zhejiang, China  \n3 Department of Pathology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China  \n4 Department of Neurosurgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n* These authors contributed equally to this work.  \nABSTRACT  \nBackground. Glioma, a highly aggressive brain tumor, presents significant challenges in prognosis and treatment. This study investigates the role of PTX3 expression in glioma and its correlation with patient outcomes, addressing a gap in current research regarding its molecular mechanisms.  \nMaterials and Methods. RNA sequencing data and clinical information for glioma patients were obtained from The Cancer Genome Atlas (TCGA) . A multigene prognostic signature based on IL-18 signaling-related genes (ISRGs) was constructed using the least absolute shrinkage and selection operator (LASSO) Cox regression method. The functional roles of PTX3 were analyzed through Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) . Single-sample GSEA (ssGSEA) was used to assess the association between PTX3 expression and immune cell infiltration. The relationship between PTX3 expression and clinicopathological features was also examined. Prognostic relevance was evaluated using univariate and multivariate Cox regression models, and Kaplan􀀕 Meier survival analysis was performed. PTX3 protein expression was validated via immunohistochemistry in 56 glioma specimens.  \nResults. The LASSO Cox regression model identified a nine-gene prognostic signature, including BMP2, NCF1, HSPB1, PIGT, PTX3, CCNA2, CCNB2, CCN4, and DES. Functional enrichment analysis revealed that PTX3-associated differentially expressed genes were significantly enriched in pathways such as cytokine􀀕cytokine receptor interaction and PI3K-Akt signaling, which are critical for immune response and cell proliferation in glioma. PTX3 expression showed a strong correlation with immune cell infiltration, particularly macrophages, neutrophils, T cells, and natural killer cells, suggesting a role in modulating the tumor microenvironment. Pan-cancer analysis indicated that PTX3 is markedly upregulated in various cancers, especially gliomas, highlighting its potential as a biomarker. PTX3 expression was also associated with clinical features such as WHO grade, IDH mutation status, and 1p/19q co-deletion, with higher PTX3 levels linked to  \nHow to cite this article Wang D, Liu C, Sun B, Zhang X, Zhou Y, Hu Z, Cao D, Zhang J, Xu J. 2025. Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients. PeerJ 13:e19675 [http://doi.org/10.7717/peerj.19675](http://doi.org/10.7717/peerj.19675)  \npoorer survival outcomes. Immunohistochemistry confirmed elevated PTX3 protein expression in both lower-grade glioma and glioblastoma multiforme.  \nConclusions. These findings highlight the critical role of PTX3 in glioma and suggest its potential as both a prognostic biomarker and therapeutic target. This st","cbCaibv1354pKWpV","https://ap.wps.com/l/cbCaibv1354pKWpV","pdf",26115485,26,"English","# Abstract\n# Introduction\n## Background on glioma and prognosis\n## IL-18 signaling and immune mechanisms\n# Materials and Methods\n## Data source and cohort\n## Prognostic signature construction\n## Functional enrichment and pathway analysis\n## Immune infiltration assessment\n## Statistical survival analyses\n## Experimental validation\n# Results\n## Prognostic gene signature\n## PTX3-associated pathway enrichment\n## Correlation with immune infiltration\n## Associations with clinicopathological features\n## Immunohistochemistry validation\n# Conclusions","[{\"question\":\"What question does the study address about PTX3 in glioma?\",\"answer\":\"The study investigates PTX3 expression in glioma and how it correlates with patient prognosis and clinicopathological features, motivated by insufficient understanding of PTX3’s molecular mechanisms.\"},{\"question\":\"How was the prognostic signature constructed?\",\"answer\":\"A multigene prognostic signature was built from IL-18 signaling-related genes using LASSO Cox regression, resulting in a nine-gene signature including PTX3.\"},{\"question\":\"How were immune infiltration and PTX3 relationships evaluated?\",\"answer\":\"Single-sample GSEA (ssGSEA) assessed associations between PTX3 expression and immune cell infiltration, and results highlighted correlations particularly with macrophages, neutrophils, T cells, and natural killer cells.\"}]","Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients | PDF",1790192562,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54e1d5a4f998a620ede9db326bd832b4.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ece18daa23fc80078c6d2b80e535d7d.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a19050a7b090ceb6d887c7303b1b6128.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d460c35acbdea6b07cc39ec8d342eecb.webp",980,1268]